Sean Lybrand
Executive Director of International Health Systems at Amgen
- Experienced, results-focused access and policy leader, demonstrating success at local, regional and global levels across different cultural contexts.
- Driven by the central premise that pharmaceutical companies are partners in the improvement of health outcomes, along with payers, advocacy organisations, and consumers
- Highly competent in pharmaceutical and vaccine access issues, pricing and reimbursement activities, policy and advocacy engagement, and industry representation, and how these translate into positive stakeholder outcomes
- Strong cross-functional and team leadership ability - ensuring that the broader team is committed to the goals of improved access to medicines
- Country Leadership Team experience in guiding strategic direction of subsidiary and building the presence and capabilities of a biopharmaceutical company in multiple therapeutic areas
Visit website: https://biography.omicsonline.org/australia/amgen/sean-lybrand-488410
See also: Amgen - Biotechnology company that develops and manufactures human therapeutics for various illness and diseases
Details last updated 18-Mar-2022
Sean Lybrand is also referenced in the following:
Global launch: Delivering prevention in an ageing world
07-Apr-2022
Event about prevention in an ageing organized by International Longevity Centre UK